(Q37738319)

22 August 2017

1 reference

title

Therapeutic strategies for diabetic neuropathy (English)

1 reference

22 August 2017

Ali A Habib

1

1 reference

PubMed ID

20425233

22 August 2017

Thomas H Brannagan

series ordinal

2

1 reference

22 August 2017

1 March 2010

1 reference

Current Neurology and Neuroscience Reports

22 August 2017

1 reference

22 August 2017

10

1 reference

22 August 2017

92-100

1 reference

22 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s11910-010-0093-7

22 August 2017

0 references

cites work

The spectrum of neuropathy in diabetes and impaired glucose tolerance

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11910-010-0093-7

Cigarette smoking and neuropathy in diabetic patients

21 January 2018

1 reference

12 December 2020

Improvement in chronic ischemic neuropathy after intramuscular phVEGF165 gene transfer in patients with critical limb ischemia

1 reference

12 December 2020

Elevated triglycerides correlate with progression of diabetic neuropathy

1 reference

12 December 2020

A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.

1 reference

12 December 2020

The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study

1 reference

12 December 2020

Advances in the management of diabetic peripheral neuropathy

1 reference

12 December 2020

Ranirestat for the management of diabetic sensorimotor polyneuropathy

1 reference

12 December 2020

Does impaired glucose metabolism cause polyneuropathy? Review of previous studies and design of a prospective controlled population-based study.

1 reference

12 December 2020

Epidermal nerve fiber quantification in the assessment of diabetic neuropathy

1 reference

12 December 2020

Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion

1 reference

12 December 2020

Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?

1 reference

12 December 2020

The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort.

1 reference

12 December 2020

Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group

1 reference

12 December 2020

Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy

1 reference

12 December 2020

Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders

1 reference

12 December 2020

Effects of an aldose reductase inhibitor, epalrestat, on diabetic neuropathy. Clinical benefit and indication for the drug assessed from the results of a placebo-controlled double-blind study

1 reference

12 December 2020

Vascular risk factors and diabetic neuropathy

1 reference

12 December 2020

Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial

1 reference

12 December 2020

5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.

1 reference

12 December 2020

Sensory neuropathy in non-insulin-dependent diabetes mellitus. The San Luis Valley Diabetes Study

1 reference

12 December 2020

Symptoms of sensory neuropathy in adults with NIDDM in the U.S. population

1 reference

12 December 2020

Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study

1 reference

12 December 2020

Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes.

1 reference

12 December 2020

Hypertension as a risk factor for diabetic neuropathy: a prospective study

1 reference

12 December 2020

Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses

1 reference

12 December 2020

Aldose reductase inhibition in the treatment of diabetic neuropathy: where are we in 2004?

1 reference

12 December 2020

Epidemiology of peripheral neuropathy

1 reference

12 December 2020

Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus

1 reference

12 December 2020

Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study

1 reference

12 December 2020

Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy.

1 reference

12 December 2020

Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort.

1 reference

12 December 2020

The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis

1 reference

12 December 2020

Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study.

1 reference

12 December 2020

Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).

1 reference

12 December 2020

Subclinical neuropathy among Diabetes Control and Complications Trial participants without diagnosable neuropathy at trial completion: possible predictors of incident neuropathy?

1 reference

12 December 2020

Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies

1 reference

12 December 2020

Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group

1 reference

12 December 2020

The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT)

1 reference

12 December 2020

Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study

1 reference

12 December 2020

Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: a randomized, double-blinded trial

1 reference

12 December 2020

Diabetic autonomic neuropathy and cardiovascular risk. Pittsburgh Epidemiology of Diabetes Complications Study III

1 reference

12 December 2020

Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia

1 reference

12 December 2020

VEGF 164 gene transfer by electroporation improves diabetic sensory neuropathy in mice

1 reference

12 December 2020

Susceptibility to diabetic neuropathy in patients with insulin dependent diabetes mellitus is associated with a polymorphism at the 5' end of the aldose reductase gene

1 reference

12 December 2020

Is peripheral neuropathy associated with retinopathy and albuminuria in individuals with impaired glucose metabolism? The 1999-2000 AusDiab

1 reference

12 December 2020

The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

10.1007/S11910-010-0093-7

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20425233